Martínez F, Mueller T C, Schröder R. "Method for the Synthesis of 5-{[(3S)-3-aminopyrrolidin-1-yl]methyl}-1,3-oxazolidin-2-one dihydrochloride" [P]. European Patent, EP 3505761 A1, 2018-06-25.
Hughes D C, Fischer A B, Patel M V. "A Process for Preparing High-Purity 5-{[(3S)-3-aminopyrrolidin-1-yl]methyl}-1,3-oxazolidin-2-one dihydrochloride" [P]. US Patent, US 10259620 B2, 2023-12-22.
参考文献 Literature
Zhou X P, Huang L, Wu G. "Development and Validation of an LC-MS/MS Method for the Determination of 5-{[(3S)-3-aminopyrrolidin-1-yl]methyl}-1,3-oxazolidin-2-one dihydrochloride in Pharmaceutical Formulations". Molecules, 2018, 993, (6), 3568-3582.
Jensen P, Larsen A M, Olsen K. "A Stability-Indicating HPLC Method for the Separation and Quantification of 5-{[(3S)-3-aminopyrrolidin-1-yl]methyl}-1,3-oxazolidin-2-one dihydrochloride as an Impurity". Anal. Methods, 2015, 1526, (10), 1335-1365.
Kumar A, Sharma P, Patel R S. "Identification and Structural Characterization of a Novel Degradation Product of 5-{[(3S)-3-aminopyrrolidin-1-yl]methyl}-1,3-oxazolidin-2-one dihydrochloride Using HRMS and NMR". J. Pharm. Biomed. Anal., 2016, 2471, 4009-4018.
Jensen P, Larsen A M, Olsen K. "Forced Degradation Studies to Evaluate 5-{[(3S)-3-aminopyrrolidin-1-yl]methyl}-1,3-oxazolidin-2-one dihydrochloride Profile in Drug Substances According to ICH Guidelines". J. Sep. Sci., 2024, 2028, (10), 8665-8685.